explore -WSS

explore

author：leisure time 2025-09-29 12:09:10 - browse：49674

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： First Opinion Podcast: What happens when kids become caregivers?

WSS

STAT Executive Editor Rick Berke on STAT's 8th birthday

Senate panel clears PBM, hopsital reforms

Just how powerful is the placebo effect?

MoonLake credibility takes another hit with mid

A clever new way to fix Medicaid and graduate medical education

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

hotspot

explore

focus

Wildfire smoke exposes gaps in outdoor worker protections

Report: NIH

DIEP, the 'gold standard' of breast reconstruction, is under threat

Free speech concerns arise in wake of journal editor Eisen's firing

Peter Hotez and the public health issue of online harassment

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Report: NIH

Bright Health sells Medicare Advantage business to Molina

UCSF medical school apologizes for unethical prisoner experiments

entertainment

MoonLake credibility takes another hit with mid

UCSF medical school apologizes for unethical prisoner experiments

Focused ultrasound for uterine fibroids: an uphill battle

10 million people disenrolled from Medicaid over past six months

Biohaven protein

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

entertainment

knowledge

focus

knowledge